	US 11,732,250 B2
	Lipase enzymes
Katie Kline, San Diego, CA (US); Adrienne Huston Davenport, San Diego, CA (US); Xuqiu Tan, San Diego, CA (US); Oliver Spangenberg, Ludwigshafen (DE); Claudia Esper, Ludwigshafen (DE); and Amy Migliori, San Diego, CA (US)
Assigned to BASF SE, Ludwigshafen (DE)
Appl. No. 17/50,117
Filed by BASF SE, Ludwigshafen (DE)
PCT Filed Apr. 24, 2019, PCT No. PCT/EP2019/060508 § 371(c)(1), (2) Date Oct. 23, 2020, PCT Pub. No. WO2019/206994, PCT Pub. Date Oct. 31, 2019.
Claims priority of provisional application 62/662,877, filed on Apr. 26, 2018.
Claims priority of application No. 18194564 (EP), filed on Sep. 14, 2018.
Prior Publication US 2021/0095266 A1, Apr. 1, 2021
Int. Cl. C12N 9/20 (2006.01); C11D 3/386 (2006.01)

CPC C12N 9/20 (2013.01) [C11D 3/38627 (2013.01); C11D 3/38663 (2013.01); C12Y 301/01003 (2013.01)]

11 Claims

1. A polypeptide having lipase activity comprising an amino acid sequence that has at least 90% sequence identity to the full length amino acid sequence of SEQ ID NO:1, wherein the polypeptide comprises at least one amino acid residue substitution at an amino acid residue position number 14, 64, 67, 145, 263, 265, 266, 291, 293, 297, 298, 303, 310, 347, 377 or 407, based on the amino acid sequence of SEQ ID NO:1.